ASCO ANNUAL MEETING

The American Society of Clinical Oncology (ASCO) Annual Meeting is the largest, most academically advanced, and most influential oncology event globally. Held annually in Chicago, USA, it brings together oncology experts, researchers, clinicians, pharmaceutical company representatives, and related medical practitioners from around the world. The ASCO Annual Meeting is not only an important platform for presenting the latest oncology research findings and exchanging clinical experiences but also a key force in advancing global oncology development and changing the landscape of cancer treatment. With a long history, since its first inception in 1964, it has become synonymous with innovation and collaboration in the field of oncology. Each annual meeting attracts tens of thousands of participants and features thousands of high-quality research abstracts and clinical study reports, covering all aspects of cancer prevention, diagnosis, treatment, rehabilitation, and palliative care. The conference content is rich and diverse, including plenary sessions, special symposia, oral presentations, poster displays, and educational courses, aiming to provide attendees with cutting-edge scientific knowledge and practical clinical skills. The strong influence of the ASCO Annual Meeting is reflected in its role in shaping global oncology treatment guidelines, guiding new drug development directions, and improving clinical practice. It provides an unparalleled platform for the oncology community, fostering international academic cooperation and accelerating the translation of cancer research findings into clinical applications, ultimately benefiting cancer patients worldwide. Participating in the ASCO Annual Meeting means standing at the forefront of global oncology research and grasping the latest pulse of industry development.

The exhibit range of the ASCO Annual Meeting covers the latest technologies, products, and services in the field of oncology, aiming to provide attendees with one-stop solutions. The exhibition content is extremely rich and includes, but is not limited to: various anti-cancer drugs, such as chemotherapy drugs, targeted therapy drugs, immunotherapy drugs (PD-1/PD-L1 inhibitors, CAR-T cell therapy, etc.), endocrine therapy drugs, biologics; advanced tumor diagnostic technologies and equipment, including genomic sequencing technologies (NGS), liquid biopsy technologies, molecular diagnostic kits, pathology diagnostic equipment, imaging diagnostic equipment (CT, MRI, PET-CT, etc.), endoscopy systems; radiation therapy equipment and technologies, such as linear accelerators, proton therapy systems, heavy ion therapy systems, radiation therapy planning systems, dosimetry equipment; surgical instruments and equipment, including minimally invasive surgical instruments, robot-assisted surgical systems, tumor ablation equipment; supportive care and palliative care products, such as pain medications, nutritional support products, anti-nausea medications, psychological support services; medical information technology and data management systems, such as electronic medical record systems, clinical trial management systems, big data analytics platforms, AI-assisted diagnostic systems; biobanks and biotechnology services, including cell culture, gene editing, proteomics research services; as well as various medical publications, professional journals, educational and training materials. In addition, numerous cancer research institutions, pharmaceutical companies, biotechnology companies, medical device manufacturers, and CROs (Contract Research Organizations) also exhibit, showcasing their latest research achievements and innovative services. These exhibits collectively form the robust academic and commercial ecosystem of the ASCO Annual Meeting, providing a solid foundation for advancing the field of oncology.

No fee information available. Please contact us for a quote.